Skip to Main Content

Paper Details

Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery.
Gastroenterology
26
2022
Crohn's & Colitis, IBD, Inflammatory Bowel Disease, Patients, SSI, SSIs, TNFi, TNFis, Tumor Necrosis Factor, inflammatory bowel disease, patients, surgical site infections, tumor necrosis factor
Author NameAffiliation
Benjamin L CohenIcahn School of Medicine at Mount Sinai, Cleveland Clinic Foundation
Phillip FleshnerCedars-Sinai Medical Center
Sunanda V KaneMayo Clinic
Corey A SiegelDartmouth Hitchcock Medical Center
Bruce E SandsIcahn School of Medicine at Mount Sinai
  • 1 - 5

Datasets

Release 1.2